Combining lipidomics and machine learning to identify lipid biomarkers for nonsyndromic cleft lip with palate.

Journal: JCI insight
PMID:

Abstract

Nonsyndromic cleft lip with palate (nsCLP) is a common birth defect disease. Current diagnostic methods comprise fetal ultrasound images, which are mainly limited by fetal position and technician skills. We aimed to identify reliable maternal serum lipid biomarkers to diagnose nsCLP. Eight-feature selection methods were used to assess the dysregulated lipids from untargeted lipidomics in a discovery cohort. The robust rank aggregation algorithm was applied on these selected lipids. The data were subsequently processed using 7 classification models to retrieve a panel of 35 candidate lipid biomarkers. Potential lipid biomarkers were evaluated using targeted lipidomics in a validation cohort. Seven classification models and multivariate analyses were constructed to identify the lipid biomarkers for nsCLP. The diagnostic model achieved high performance with 3 lipids in determining nsCLP. A panel of 3 lipid biomarkers showed great potential for nsCLP diagnosis. FA (20:4) and LPC (18:0) were also significantly downregulated in early serum samples from the nsCLP group in the additional validation cohort. We demonstrate the applicability and robustness of a machine-learning algorithm to analyze lipidomic data for efficient and reliable biomarker screening.

Authors

  • Shanshan Jia
    National Engineering Laboratory for Video Technology, School of Electronics Engineering and Computer Science, Peking University, Beijing, China; Peng Cheng Laboratory, Shenzhen, China.
  • Weidong Xie
    School of Computer Science and Engineering, Northeastern University, Shenyang, China.
  • Chunqing Yang
    State Key Laboratory of Chemical Safety, College of Control Science and Engineering, China University of Petroleum (East China), Qingdao 266580, China.
  • Yizhang Dong
    Key Laboratory of Health Ministry for Congenital Malformation, Shengjing Hospital of China Medical University, Shenyang, China.
  • Wenting Luo
    Key Laboratory of Health Ministry for Congenital Malformation, Shengjing Hospital of China Medical University, Shenyang, China.
  • Hui Gu
    Key Laboratory of Health Ministry for Congenital Malformation, Shengjing Hospital of China Medical University, Shenyang, China.
  • Xiaowei Wei
    Reproductive Medicine Center, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wei Ma
    Institute of Urban Agriculture, Chinese Academy of Agricultural Sciences, Chengdu, China.
  • Dan Liu
    Department of Bioengineering, Temple University, Philadelphia, PA, United States.
  • Songying Cao
    Key Laboratory of Health Ministry for Congenital Malformation, Shengjing Hospital of China Medical University, Shenyang, China.
  • Yuzuo Bai
    Department of Pediatric Surgery, Shengjing Hospital of China Medical University, Shenyang, China.
  • Wei Li
    Department of Nephrology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
  • Zhengwei Yuan
    Key Laboratory of Health Ministry for Congenital Malformation, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.